MGC Pharma: Pushing the envelope of phytocannabinoid-based research
Home > Media mentions > MGC Pharma: Pushing the envelope of phytocannabinoid-based research
Submitted by Linda McGlone
Media Title: Health Europa
Media Type: Online
PublishDate: 11 April 2019
Headline: MGC Pharma: Pushing the envelope of phytocannabinoid-based research
Abstract: MGC Pharma has a strong relationship with Epilepsy Action Australia, the country’s peak patient advocacy association. The relationship is varied, including collaboration on research, provision of information to patients, and more. In 2019, MGC Pharma co-funded the development of C4E (www.c4e.com.au), a platform that collates information about medicinal cannabis for the thousands of patients suffering from epilepsy in Australia.